Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

THJ-2201

An indazole analogue of AM-2201, a full CB1 and CB2 agonist; US Schedule I as early as January 2015.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₃H₂₁FN₂O

CAS 1801552-01-1

Family
Synthetic CB receptor agonistNew psychoactive substance
Molar mass
360.40 g/mol

Updated on

In plain terms

THJ-2201 is a synthetic cannabinoid made in a laboratory, a variant of AM-2201 in which the indole core is replaced by an indazole. It binds very strongly to the cannabis receptors in laboratory assays. It was placed in Schedule I in the United States in January 2015 and is classified as a narcotic in France.

Receptors and activity

Target network

CB1AgonistKi = 1.3 nM · humancompetitive [3H]CP55,940 binding, CHO cell membranes
  • Activates

The lower the cited value, the closer the target sits to THJ-2201: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of THJ-2201.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1AgonistKi = 1.3 nM · human81 out of 100

    Hess et al. 2016, Forensic Toxicol (new tab) · competitive [3H]CP55,940 binding, CHO cell membranes

  2. CB2AgonistKi = 1.3 nM · human81 out of 100

    Hess et al. 2016, Forensic Toxicol (new tab) · competitive [3H]CP55,940 binding, CHO cell membranes

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

THJ-2201 is a synthetic cannabinoid of the naphthoylindazole family: the analogue of AM-2201 in which the indole core is replaced by an indazole, and the fluorinated analogue of THJ-018, with which it was identified in 2014 (Diao et al. 2016). Hess et al. (2016) measure on human receptors Ki values of 1.34 nM at CB1 and 1.32 nM at CB2; Angerer et al. (2019) measure an EC50 of 1.68 nM at CB1 in a cAMP biosensor assay. According to Diao et al., the US forensic laboratory database held 220 reports of THJ-2201 and the US Drug Enforcement Administration placed it in Schedule I in January 2015 because of numerous adverse events. In human hepatocytes they observed 27 metabolites, dominated by oxidative defluorination followed by carboxylation or glucuronidation, in silico prediction underestimating this defluorination; in human liver microsomes, Gaunitz et al. (2019) describe 46. No controlled study in human beings was found.

History

Source
A wholly synthetic molecule, with no natural occurrence. It was identified in 2014, with THJ-018, as the indazole analogue of AM-2201 (Diao et al. 2016). None of this has anything to do with hemp or with cannabidiol products.

Origin

Laboratory synthesis

No biological pathway: THJ-2201 is entirely synthetic and belongs to the chemical family of the naphthoylindazoles.

Classification

Family, origin and source verification

Family

Synthetic CB receptor agonist › New psychoactive substance

Class

naphtoylindazole

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

THJ-2201 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

IUPAC name
[1-(5-fluoropentyl)indazol-3-yl]-naphthalen-1-ylmethanone

Identifiers

Formula
C₂₃H₂₁FN₂O
CAS
1801552-01-1
InChIKey
DULWRYKFTVFPTL-UHFFFAOYSA-N
SMILES
C1=CC=C2C(=C1)C=CC=C2C(=O)C3=NN(C4=CC=CC=C43)CCCCCF

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.